Table 3.

Longer diagnostic delay effect on risk of complications and Durie-Salmon stage—multiple binary and Poisson regression models.

	Beta Value	p Value	Odds Ratio	(95% CI)
Factors included in MM 1 Complications (measured as ≤1 and >1) Regression Model
(Intercept)	−3.875	0.107	0.019	-
E 2 interval duration, range 23–1800 days	0.003	0.024	1.003	1.000–1.006
Gender: 1—male, 2—female	−0.752	0.255	0.471	0.129–1.720
Age, range 19–84 years	0.035	0.329	1.035	0.966–1.110
CIRS index value, range 3–12	−0.050	0.707	0.951	0.733–1.234
Factors included in MM 1 Durie-Salmon stage (measured as 1 = 1A, 2 = IB, etc.) regression model
(Intercept)	0.644	0.218	1.904	-
E 2 interval duration, range 23–1800 days	0.001	0.049	1.001	1.000–1.001
Gender: 1—male, 2—female	−0.160	0.261	0.085	0.644–1.127
Age, range 19-84 years	0.010	0.216	1.010	0.994–1.026
CIRS index value, range 3–12	0.015	0.580	1.016	0.962–1.072

¹—multiple myeloma. ²—overall time between symptom onset and diagnosis (sum of A, B, C intervals).